PALYNZIQ
Google image searchProduct monograph
Active ingredient
pegvaliase, 2.5 MG/0.5 ML
DIN: 02526247
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription / Schedule D
Company: BIOMARIN INTERNATIONAL LIMITED
Date: 26-AUG-2022
ATC:
- A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
- A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
- A16AB — Enzymes (ATC, ATC/DDD)
- A16AB19 — PEGVALIASE (ATC/DDD)
Reference brand drug: Palynziq
